Science / Drugs MVST IB - part 1

Random Science Quiz

Can you name the drugs from MVST IB - part 1?

Quiz not verified by Sporcle

Forced Order
Challenge
Share
Tweet
Embed
Score 0/156 Timer 20:00
DescriptionDrug nameUse
Regulates expression of multiple angiogenic genes
Irreversible alpha-adrenoceptor antagonist - blocks Uptake 2 (and Uptake 1 at 10x higher concs)
Illegal drug - blocks NET
Indirectly-acting sympathomimetic amine - weak inhibitor of MAO
Local anaesthetic - uncharged
Beta-1 antagonist used in heart failure
Naturally occurring anticoagulant produced by basophils/mast cells - exposes active site of antithrombin III
SSRI - blocks 5-HT transporter in Uptake 1
Converted to alpha-methylNA - released as false transmitter - more potent at alpha-2, less potent at alpha-1
Interferes with normal function of microtubule growth
Cholinergic agonist - not selective between nicotinic/muscarinic receptors
Alpha-2 antagonist (some effect on alpha-1)
Non-selective agonist for muscarinic receptors
Glucocorticoid receptor antagonist
Local anaesthetic (ester, weak base) - broken down by BuChE
K channel opener - also hirsutism effects
Inodilator used to treat canine dilated cardiomyopathy - calcium sensitiser
PPAR-gamma agonist
Beta-adrenoceptor agonist
Monoclonal antibody against glycoprotein IIb/IIIa receptor - prevents platelet aggregation - also binds to vitronectin receptor
Loop diuretic - blocks Na/K/2Cl transport in thick ascending limb
Selective MAO-A inhibitor
Selective inhibitor of phosphodiesterase type V (selectively breaks down cGMP)
Selective inhibitor of NOS in neurons
Non-specific endothelin receptor antagonist
Binds to synaptobrevin to prevent vesicle release from inhibitory interneuron synapses with motor neurons
Potassium-sparing diuretic - blocks apical Na+ channels in late distal tubule
Tyrosine kinase inhibitor
Non-selective alpha-adrenoceptor antagonist
Calcium sensitiser - increases cardiac Ca2+ binding efficiency to troponin - inhibits phosphodiesterase III
Blocks transporter carrying ACh into storage vesicles
Irreversibly alkylates muscarinic receptor
Nicotinic receptor antagonist - relatively non-selective between NMJ and ganglion at clinical doses
Single chain recombinant human tissue plasminogen activator
Lowers VLDL (and LDL) by stimulating lipoprotein lipase - may activate PPARs
Indirectly acting sympathomimetic amine - converted to octopamine by DBH - found in various foodstuffs
Calcium channel antagonist - dihydropyridine - affects L-type but not T-type channels
Competitively inhibits plasminogen activation - inhibits severe bleeding from excessive clot lysis
Depolarising blocker selective for NMJ nicotinic receptor - very short duration of action, broken down by BuChe - deficiency in enzyme activity can lead to prolonged action
Selective MAO-B inhibitor
ADP-ribosylates alpha-i - prevents activation of Gi in response to stimulation
Irreversible antagonist at nicotinic NMJ receptors (no effect on ganglionic receptors)
Selective non-depolarising neuromuscular blocker at NMJ - ester, broken down by spontaneous hydrolysis and plasma esterases
K channel opener - also NO donor
Binds to plasminogen activator, increasing generation of plasmin
NSAID used to prevent thrombosis
Intracellular tetravalent polyamine - helps produce inward rectification of K+ channels
Direct acting vasodilator - metabolised to NO or cyanide
Nitrovasodilator - produces NO - taken sublingually
Plasminogen + anisoylated streptokinase
Progestagen receptor antagonist
Involved with providing new blood flow to ischaemic tissues
DescriptionDrug nameUse
ADP-ribosylates alpha-s - inhibits GTPase activity - sustained activation of adenylyl cyclase
Angiotensin II partial agonist
Used experimentally to inhibit dopamine beta-hydroxylase - also inhibits aldehyde dehyddrogenase
Mild partial beta-1 agonist
Reverse inhibition of AChE by organophosphorus agents
Thiazide diuretic - blocks Na/Cl transport in early distal tubule
K channel opener
Use-dependent block of ganglionic transmission
Irreversible anticholinesterase - organophosphorus agent
Binds very tightly to VMAT-2, preventing loading of catecholamines into vesicles
Medium 'reversible' anticholinesterase - binds to esteratic site and carbamoylates ACh
Blocks uptake of choline into neurons
Inhibits HMG-CoA reductase - also many pleiotropic effects
Non-selective, reversible MAO inhibitor
Class IC antidysrhythmic
Inhibits clotting by inhibiting synthesis of factors II, VII, IX, IX and regulatory proteins C, S, Z
Phosphodiesterase III inhibitor - inodilator
Non-peptide angiotensin II antagonist - acts on AT1 receptors
Partial agonist at alpha-adrenoceptors - 5-HT agonist
Binds to neurexins, causing massive ACh release from nerve terminals
Selective non-depolarising neuromuscular blocking agent at NMJ - long action, not hydrolysed
Depolarising blocker at NMJ
Class III antidysrhythmic - prolongs AP and refractory period
Estrogen receptor antagonist
Non-selective agonist for muscarnic receptors
Cholinergic agonist - +-isomer hydrolysed by AChE
Selective alpha-2 agonist
Non-selective phosphodiesterase inhibitor
Blocks transport of adenosine into cells - phosphodiesterase type V inhibitor
Non-selective phosphodiesterase inhibitor
Tricyclic antidepressant - blocks NET
Non-selective beta-adrenoceptor antagonist
Mineralocorticoid receptor agonist
Progestagen receptor agonist
Estrogen receptor agonist
Very potent alpha-2 agonist
Competitive inhibitor of tyrosine hydroxylase
Reversible anticholinesterase - ionic interaction
Competitively inhibits plasminogen activation - inhibits severe bleeding from excessive clot lysis
Muscarinic receptor antagonist - very long duration of action
Competitive antagonist for ganglionic nicotinic receptor - inactive at NMJ
ACE inhibitor
Orally-acting hypoglycaemic agent - sulphonylurea
Selective antagonist for M3 muscarinic receptor
Inhibits DOPA decarboxylase in periphery
Calcium channel agonist - dihydropyridine
Mineralocorticoid receptor antagonist - potassium-sparing diuretic
Selective beta-1 antagonist (slight effect on beta-2)
Beta-1 agonist - weak beta-2 agonist
Glucocorticoid receptor agonist
Selective antagonist for M1 muscarinic receptors
Local anaesthetic - slow onset/offset - use dependence at low rates of stimulation - class IA antidysrhythmic
DescriptionDrug nameUse
Inhibits platelet activation by inhibiting binding of ADP to its receptor on platelets
Nitrovasodilator - produces NO - metabolised in liver to active drug
Muscarinic receptor agonist
Slightly selective alpha-2 agonist (also alpha-1 actions) - omitting dose can lead to rebound hypertension
Cyclic heptapeptide inhibitor of glycoprotein IIb/IIIa receptor
Orally-acting hypoglycaemic agent - sulphonylurea
A1 receptor antagonist - non-selective phosphodiesterase inhibitor
Quaternary local anaesthetic analogue - only effective if perfused inside cells
Inhibits liver triglyceride production and VLDL secretion - increases levels of tissue plasminogen activator
Beta-1 antagonist used in heart failure
ACE inhibitor - prodrug, must be metabolised in liver
Inhibits intestinal absorption of cholesterol - circulates enterohepatically
Blocks If current in SA node
Irreversible anticholinesterase - activated by replacement of sulphur atom with oxygen, deoxified by plasma carboxylesterases
Potassium-sparing diuretic - blocks apical Na+ channels in late distal tubule
Blocks release of NA evoked by APs (repeated low doses/aftermath of large dose) - indirect sympathomimetic actions (large doses)
Anion exchange resin - prevents reuptake of bile acids from intestine
Depolarising blocker selective for ganglion nicotinic receptor
Selective alpha-1 antagonist (slight effect on alpha-2)
Nitrovasodilator - produces NO
Tricyclic antidepressant - blocks NET
Selective alpha-2 antagonist (slight effect on alpha-1)
Acts on imidazoline receptors
Blocks release of neurotransmitter via phospholipase A2 - localises to membrane by K channel binding moiety
Non-peptide inhibitor of glycoprotein IIb/IIIa receptor
Blocks Na channels from exterior - no use-dependence
Immunosuppressant drug with antiproliferative effects
Carbonic anhydrase inhibitor
Co-released with NA or ACh - acts on purinoceptors (P2 > P1)
Selective beta-2 antagonist (slight effect on beta-1)
Calcium channel blocker - benzothiazepine
Arteriolar vasodilator - unknown mechanism
Calcium channel blocker - phenylalkylamine - class IV antidysrhythmic
Double chain recombinant human tissue plasminogen activator
Selective alpha-1 agonist (some action on beta-1)
Uncompetitive inhibitor of phosphatase acting on IP1 --> inositol
Osmotic diuretic - filtered at glomerulus, not reabsorbed
COMT inhibitor
K channel opener
Acts on imidazoline receptors
alpha-1 antagonist most commonly used
NOS inhibitor - not very selective for different forms
Potent, irreversible inhibitor of iNOS in activated macrophages
Binds to SNAREs involved in membrane fusion, preventing ACh release
Combined alpha- and beta-adrenoceptor antagonist
Experimental cardiac glycoside
Local anaesthetic - weak base - use-dependence and voltage-dependence
Selective beta-2 agonist (slight effect on beta-1)
Causes development of new blood vessels
Competitive antagonist for ganglionic nicotinic receptors - inactive at NMJ
Cardiac glycoside - inhibits Na/K-ATPase
Phosphodiesterase III inhibitor - inodilator

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
OR
Log In

You Might Also Like...

Show Comments

Extras


Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.